双能CT特征预测胰腺癌新辅助治疗后手术淋巴结阳性的价值
回顾性纳入62例接受新辅助治疗及切除术的胰腺导管腺癌患者,于术前双能CT碘密度图上测量淋巴结碘浓度并归一化至主动脉。术前所有测量淋巴结的最小归一化碘值在区分N0与N1/2时P=0.041,AUC为0.67,阈值0.2857时敏感度0.78、特异度0.58,低于该值提示N1/2;淋巴结形态及大小变化无统计学意义。
要点
- 术前双能CT所有测量淋巴结的最小归一化碘值有助于区分N0与N1/2,AUC 0.67。
- 阈值0.2857时敏感度0.78、特异度0.58,低于该值提示N1/2。
- 淋巴结形态及大小变化在区分N0与N1/2中无统计学意义。
核心结论
- 术前双能CT手术野内所有淋巴结的最小归一化碘值在区分N0与N1/2方面具有中等效用,总体优于常规特征。
研究设计与样本
- 经IRB批准的回顾性研究,纳入2012年至2016年间62例经证实的胰腺导管腺癌患者,均接受新辅助治疗、肿瘤切除及基线和术前胰腺多期快速切换双能CT评估。
- 由3名放射科医师共识识别短径>0.5 cm的淋巴结,评估淋巴结形态、大小及各期密度(HU),并在碘密度图上测量归一化至主动脉的碘浓度。
关键影像表现/征象
- 共评估145枚淋巴结,各解剖部位平均淋巴结数从1.3枚(体部肿瘤)到5枚(钩突)不等,而手术分别回收平均24枚和30枚淋巴结。
- 大多数(N=44)为胰头肿瘤。
诊断标准与关键数值
- 对于所有患者,无论原发肿瘤部位,术前检查中患者所有测量淋巴结作为一个整体,其最小归一化碘值在区分N0与N1/2时P=0.041,ROC分析AUC为0.67。
- 以0.2857为阈值,敏感度0.78、特异度0.58,低于0.2857提示N1/2。
临床应用与阅片要点
- 术前双能CT碘密度图测量手术野内所有淋巴结的最小归一化碘值,可能有助于术前识别淋巴结阳性(N1/2)。
- 淋巴结形态及大小变化在区分N0与N1/2中无统计学意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Evaluate utility of dual energy CT iodine material density images to identify preoperatively nodal positivity in pancreatic cancer patients who underwent neoadjuvant therapy.
METHODS: This IRB approved retrospective study evaluated 62 patients between 2012 and 2016 with proven pancreatic ductal adenocarcinoma, who underwent neoadjuvant therapy, tumor resection and both baseline and preoperative assessment with pancreatic multiphasic rapid switching dual energy CT. Three radiologists in consensus identified on imaging nodes > 0.5 cm in short axis, evaluated nodal morphology, size and on each phase density in HU, and concentrations on iodine material density images normalized to the aorta.
RESULTS: Of 62 patients, 33 were N0, 20 N1, and 9 N2. Total of 145 lymph nodes were evaluated, with average number of nodes per anatomic site ranging from 1.3 (body tumors) to 5 (uncinate) versus average of 24 and 30 nodes recovered respectively at surgery. Most (N = 44) were pancreatic head tumors. For all patients, regardless of site of primary tumor, the minimum measured iodine value of all of a patient's measured nodes taken as a group on preoperative studies, as normalized to the aorta, was significant at P = 0.041 value in differentiating N0 from N1/2 and ROC analysis showed an AUC of 0.67. With a cutoff of 0.2857, sensitivity was 0.78 and specificity was 0.58, with values < 0.2857 indicative of N1/2. Node morphology and changes in nodal size weren't statistically significant.
CONCLUSION: The dual energy based minimum normalized iodine value of all nodes in the surgical field on preoperative studies has modest utility in differentiating N0 from N1/2, and generally outperformed conventional features for identifying nodal metastases.
引用
- Le O, Javadi S, Bhosale PR, et al. CT features predictive of nodal positivity at surgery in pancreatic cancer patients following neoadjuvant therapy in the setting of dual energy CT. Abdom Radiol (NY). 2021. PMID: 33471129. doi:10.1007/s00261-020-02917-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。